2025 ISPE Aseptic Conference

Conference Overview 

The 2025 ISPE Aseptic Conference serves as a platform where the newest developments in aseptic processing, robotics, and automation are explored in depth. It addresses the complex challenges associated with sterilizing small-batch aseptic products and accelerating their time-to-market.

The conference will deep-dive into the revised Annex 1’s implications, setting new benchmarks for sterile product manufacturing, Quality Risk Management, Contamination Control Strategy, and compliance for computerized systems.

Key topics at the conference include emerging aseptic technologies such as microbiological and online testing, and case studies showcasing flexible and multi-product facilities’ success stories. Participants can look forward to gaining critical insights into small-scale manufacturing for development and clinical trials, managing high potent compounds, containment strategies, and ensuring sterility.

Furthermore, attendees will learn how to navigate fill-finish tech transfer challenges, integrate robotics effectively, select optimal primary packing options, and implement aseptic procedures seamlessly. The conference will also provide answers to queries about parenteral production, lyophilization, sterilization processes, and GMP practices.

The aseptic conference offers opportunities to interact with your peers and leaders in the industry in networking and workgroup meetings to help you discover ideas that can give you fresh perspective on your operations. These relationships last a lifetime and bring technical value to your professional life. Join us at the 2025 ISPE Aseptic Conference.


Hear What Our past Attendees Are Saying


Receive Notifications

Stay up-to-date on registration, education opportunities, speakers, hotel discounts, exhibitor information, and more by signing up to receive notifications for the 2025 ISPE Aseptic Conference.

Name
Company Type
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

International Program Committee

Christa B. Myers
Sr. Fellow - Aseptic and Sterile Products, Vertical Market Leader
CRB
Chair
Norman A. Goldschmidt
President
Genesis AEC
International Board and Foundation Liaison
Nidhi C. Shah
Senior Director, Value Stream CAR - T Manufacturing Operations
Bristol Myers Squibb
Women in Pharma® Liaison
Erich H. Bozenhardt
Associate Director Process Engineering, Regenerative Medicine
United Therapeutics
Cristina B. Brinkmann
Drug Product & Finished Goods Business Steering Group Lead
Fujifilm Diosynth Biotechnologies
Massimiliano Cesarini, MSEng
Managing Director - Life Sciences
Omnia Technologies
Richard Denk
Senior Consultant Aseptic Processing & Containment
SKAN AG
Matthew P. Gorton
Director of Business Development
GBA Life Sciences
Michael G. Higgins
Global Head Compliance and Inspection Management
Moderna
Klaus Ullherr
Senior Product Manager
Syntegon Technology GmbH
Keith W. Weseli, CPIP
Site Quality Project Director
Stevanato Group
Jörg Zimmermann
Vice President Vetter Development Service External Affairs
Vetter Pharma Fertigung GmbH & Co KG